Clicky

Hanmi Pharm Co Ltd(128940) News

128940 price today by TradingView
Date Title
Aug 6 Aptose Biosciences Moves to Higher Dose in Phase 1/2 Cancer Study After Positive Safety Review
Aug 6 Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
Jun 30 Aptose Announces Deferral of Interest Payment